Mumtaz Yaseen Balkhi

It Bio, Llc

$225,000

Attributed

$225,000

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding mix

By agency

NIH$225,000 · 1

By mechanism

R43$225,000 · 1

Top collaborators

No co-investigators on record.

Most similar at It Bio, Llc

Same institution · by research overlap

Richard P Junghans$3,250,862

Others in their field

Other Emerging Leaders on “Antibody Inhibitor”

Susan Abushakra · Alzheon, Inc.$20,190,244
Deanna A Kulpa · Emory University$8,444,989
Michael-Christopher Keogh · Epicypher, Inc.$5,851,393
Jean Kwun · Duke University$5,820,875
Timothy Nichols · Univ Of North Carolina Chapel Hill$5,542,798
Marlena Habal · Columbia University Health Sciences$5,428,816

Research focus

Antibody InhibitorAnti-Cancer TherapeuticAntigensAnti-Pd-1Anti-Pd1 AntibodiesAttentionAutologousCancer TherapyCell PhysiologyCheckpoint ReceptorsChronicClinically RelevantClinical TrialsCombined Modality TherapyCytokineCytotoxicEffector T CellEnvironmentEvaluationExhaustExhaustionExhibitsFailureAntibodies

Grant awards (1)

Co-targeting Ezh2 with PD1 to improve T cell exhaustion reversal and tumor responses$225,000

R43 · FY2019 · CA · contact PI